-
Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Mar 10, 2025, 14:00 PM -
Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women
Mar 10, 2025, 14:00 PM -
Using Real-World Data and Machine Learning to Identify Patients at Highest Risk for Hospitalization Following Respiratory Syncytial Virus Infection
Mar 10, 2025, 14:00 PM -
A Structured Literature Review on Survival, Complications, Disease Transformation, Treatment Pattern and Unmet Need Among Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab
Mar 10, 2025, 14:00 PM -
Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
Mar 10, 2025, 14:00 PM -
A Modern Approach for Constructing Decision Analytic Models in Microsoft Excel
Mar 10, 2025, 14:00 PM -
Trends in Current Smoker Profiles Among US Adults From 2019-2024: An Unsupervised Clustering Analysis
Mar 10, 2025, 14:00 PM -
Developing a Value Assessment Framework for Modified New Drugs In China
Mar 10, 2025, 14:00 PM -
Cost Opportunity of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments - Brazilian Cost Analysis
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns of First-Line (1L) Ibrutinib in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): Insights into Therapy Interruptions, Discontinuation and Next Treatment
Mar 10, 2025, 14:00 PM -
Value Communications With US Payers: The Value of Storytelling
Mar 10, 2025, 14:00 PM -
Acute Care visits and Readmissions Among Commercial Plan Enrollees with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes
Mar 10, 2025, 14:00 PM -
Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States
Mar 10, 2025, 14:00 PM -
Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis
Mar 10, 2025, 14:00 PM -
Is Poor Adherence to Good Modeling Practices Making Us Worry Too Much About Effect Modifiers? A Case Study in Moderate to Severe Plaque Psoriasis
Mar 10, 2025, 14:00 PM -
Compare the Return on Investment of Pulsed Field Ablation With Conventional Thermal Ablation for Treatment of Atrial Fibrillation in China
Mar 10, 2025, 14:00 PM -
Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Mar 10, 2025, 14:00 PM
